Clinical Trials Browser

Phase 2 × Limited Stage Small Cell Lung Cancer × durvalumab × Clear all

NCT06773910 2026-02-27

TIGOS-LS

Phase 2 Recruiting

Limited Stage Small Cell Lung Cancer

NCT05034133 2021-09-05

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Phase 2 Unknown

Limited Stage Small Cell Lung Cancer